Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

InVivoMAb Anti-HSV1/HHV1 gB/Envelope glycoprotein B (Fd79)

Catalog #:   VVV21302 Specific References (40) DATASHEET
Host species: Human
Isotype: IgG1
Applications: Blocking, ELISA, FCM
Accession: P06436
Overview

Catalog No.

VVV21302

Species reactivity

Human herpesvirus 1 (strain F) (HHV-1) (Human herpes simplex virus 1)

Host species

Human

Isotype

IgG1

Clonality

Monoclonal

Target

Envelope glycoprotein B, gB, UL27

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P06436

Applications

Blocking, ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

Fd79

Data Image
References

Salvianolic acid A acts as a herpes simplex virus dual inhibitor by blocking glycoprotein B-mediated adsorption and membrane fusion., PMID:40450985

Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus., PMID:38807208

Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies in vivo and neurovirulence., PMID:37366623

Tegument protein UL21 of alpha-herpesvirus inhibits the innate immunity by triggering CGAS degradation through TOLLIP-mediated selective autophagy., PMID:36343628

Inhibitory effects of baicalein against herpes simplex virus type 1., PMID:33354504

Identification of 22 Novel Motifs of the Cell Entry Fusion Glycoprotein B of Oncolytic Herpes Simplex Viruses: Sequence Analysis and Literature Review., PMID:32974139

Guanidine modifications enhance the anti-herpes simplex virus activity of (E,E)-4,6-bis(styryl)-pyrimidine derivatives in vitro and in vivo., PMID:31709511

Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry., PMID:25428876

Herpes simplex virus 1 glycoprotein M and the membrane-associated protein UL11 are required for virus-induced cell fusion and efficient virus entry., PMID:23678175

Activation of monocytic cells by immunostimulatory lipids conjugated to peptide antigens., PMID:22710358

Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy., PMID:22008818

Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1., PMID:20944748

Effects of phosphorylation of herpes simplex virus 1 envelope glycoprotein B by Us3 kinase in vivo and in vitro., PMID:19846518

Repeated social stress enhances the innate immune response to a primary HSV-1 infection in the cornea and trigeminal ganglia of Balb/c mice., PMID:19822203

The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity., PMID:19168902

Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters., PMID:18619637

A soluble divalent class I MHC/IgG1 fusion protein activates CD8+ T cells in vivo., PMID:15925833

Pathogenic potentials of glycoprotein C-negative syncytial mutants from rabbit T cells infected persistently with herpes simplex virus type 1., PMID:15779044

Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors., PMID:15258314

Virus infection expands a biased subset of T cells that bind tetrameric class I peptide complexes., PMID:12778473

The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells., PMID:12551982

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1., PMID:11777979

The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant., PMID:10438852

Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0., PMID:10191191

Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes., PMID:9472620

Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization., PMID:9060677

Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein., PMID:8806508

Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection., PMID:7933156

Enhancement of CTL response induced by a viral peptide using cationized BSA, a Th1-stimulating adjuvant., PMID:7576032

In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope., PMID:7504370

Monoclonal anti-idiotypes to herpes simplex virus type 1 capable of antigen specific priming & stimulatory activity., PMID:7505259

Two novel single amino acid syncytial mutations in the carboxy terminus of glycoprotein B of herpes simplex virus type 1 confer a unique pathogenic phenotype., PMID:8390747

A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1., PMID:1655317

Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies., PMID:1846388

Isoelectric focusing herpes simplex virus-gB overlay study in brainstem encephalitis., PMID:2291396

Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B., PMID:1698994

Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B., PMID:2164044

Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection., PMID:2854958

Production, binding characteristics, and immunogenicity of heterologous anti-idiotypic antibody to herpes simplex virus glycoprotein C., PMID:3509672

Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virus., PMID:3012867

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

InVivoMAb Anti-HSV1/HHV1 gB/Envelope glycoprotein B (Fd79) [VVV21302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only